W18 - Pro-Con Debate: FQ Prophy in HCT

Tuesday, October 18, 2022

10:30 AM – 11:30 AM US ET

Location: 207 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Workshop Speaker(s)

SA

Samuel L. Aitken, PharmD

The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Disclosure: Disclosure(s): Entasis Therapeutics: Advisor/Consultant (Ongoing); Glaxo Smith Kline: Advisor/Consultant (Ongoing); Melinta: Grant/Research Support (Ongoing); Shionogi: Advisor/Consultant (Ongoing)
Ghady Haidar, MD

Assistant Professor of Medicine
University of Pittsburgh School of Medicine
Pittsburg, PA, United States

Disclosure: Disclosure(s): Karius, Allovir, and AstraZeneca: Grant/Research Support (Ongoing); Karius, AstraZeneca: Advisor/Consultant (Ongoing); MDOutlook: Honoraria (Terminated); NIH/NIAID: Grant/Research Support (Ongoing)

Disclosure(s):

Samuel L. Aitken, PharmD: Entasis Therapeutics: Advisor/Consultant (Ongoing); Glaxo Smith Kline: Advisor/Consultant (Ongoing); Melinta: Grant/Research Support (Ongoing); Shionogi: Advisor/Consultant (Ongoing)

Ghady Haidar, MD: Karius, Allovir, and AstraZeneca: Grant/Research Support (Ongoing); Karius, AstraZeneca: Advisor/Consultant (Ongoing); MDOutlook: Honoraria (Terminated); NIH/NIAID: Grant/Research Support (Ongoing)